‘We plan to expand our reach to over 100 clinics’
Jiva Ayurveda recently opened its first telemedicine centre in Pune and plans to serve patients in regional languages through it.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The Journey From Cow to Consumption
Post Diwali, ColoPlus sachets will be launched in India, thanks to a collaboration between ColoPlus and the Rs 1,450 crore…
Homoeopathy Coming Out Of The Shadow
Homoeopathy is one of the oldest systems of alternative medicine. However, it has not been able to gain the same stature as its…
Sun Pharma seeks shareholders’ approval on Rs 50,000 cr provision
The company is also seeking an extension of an enabling resolution to raise up to Rs 12,000 crore via domestic and/or…
DoP recommends foolproof system to curb adverse drug reactions
India should see that its drugs manufacturing and exports register manifold increase with no suspicion in their content and…
Novartis launches access programme for 15 medicines
Novartis Access to be launched first in Kenya, Ethiopia and Vietnam
US FDA reverses NDA nod for Sun Pharma’s anti epileptic drug
Sun Pharma Advanced Research Company (SPARC) announced that the US Food and Drug Administration (US FDA) has issued a Complete…
Ajanta Pharma in NSE’s Nifty Midcap 50 index
The inclusion will take effect from October 19 this year
Department of Pharmaceuticals’ revamped website launched
The website is compliant with the guidelines issued by the Department of Administrative Reforms and Public Grievances
Dr Reddy’s, BioMarin settle patent litigation on Kuvan tablets
BioMarin will allow the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage